Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Nathaniel "Nat" Turner is a serial entrepreneur, investor, and corporate director who serves as an independent director of MOZAYYX Acquisition Corp. (NYSE: MZYX), a special purpose acquisition company that confidentially filed and made public its IPO on February 2, 2026, ultimately pricing an upsized $261 million offering. He joins the MOZAYYX board alongside Xuan Yong, Gurpreet Oberoi, Danton Hill, and James Obulaney. Turner's appointment to the SPAC's board adds to an already extensive portfolio of public-company directorships, which includes serving as a director of GameStop Corp. beginning in 2024 and as a director of Clover Health Investments Corp. (NASDAQ: CLOV) since at least January 2021. He has also served as a board member of OneOncology, a network of community oncology practices.
Turner is currently the Chief Executive Officer and Chairman of Collectors, a company focused on the collectibles industry that helps collectors buy, sell, trade, and authenticate their collections. He is also a general partner at Operator Partners, a venture capital firm. Turner's most notable entrepreneurial achievement was co-founding Flatiron Health, a data-first oncology company motivated by his cousin's leukemia diagnosis. As co-founder and CEO, he oversaw initiatives across provider solutions, life sciences, medical oncology, business development, and sales operations. Flatiron Health was acquired by Roche in 2018 for approximately $1.9 billion, representing one of the most significant healthcare technology exits of the decade. Prior to Flatiron, Turner co-founded and served as CEO of Invite Media, an advertising technology company that built the industry's first enterprise platform for buying and optimizing online media in real time; Invite Media was acquired by Google in 2010. Before Invite Media, Turner started numerous internet companies and worked at Say Media and First Round Capital.
As an active angel investor, Turner has invested in over 30 technology startups across the country, with notable portfolio companies including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. His venture investing also includes participation in Oshi Health's $23 million Series A round in October 2021, co-investing alongside Steve Kraus of Bessemer Venture Partners, Michael Greeley of Flare Capital Partners, and others. Turner has been building businesses since he was 12 years old and is known as both an avid golfer and a collector himself. He is based in New York, New York, and is a member of the World Economic Forum.
Turner earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. His track record spans three major entrepreneurial ventures—Invite Media (acquired by Google, 2010), Flatiron Health (acquired by Roche, 2018, $1.9 billion), and his current leadership of Collectors—alongside a growing public-company governance footprint across healthcare, retail, and now the SPAC sector through MOZAYYX Acquisition Corp.
This record is keyed to SEC CIK 0001838734 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 6 institutional-holder rows on these vehicles, under 4 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.